Up to 80% of patients with cirrhosis and a homozygous C282Y mutation will have a ferritin of > 1000 ng / mL, elevated AST (aspartate transaminase) and ALT (alanine transaminase), and platelet count < 200 × 10 3 / mcL (< 200 × 10 9 / L).